Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Factor VII anticorps (AA 366-466)

Cet anticorps anti-Factor VII Monoclonal Souris (Clone F7-3515) (ABIN7864702) détecte spécifiquement Factor VII dans IHC et ELISA. L’anticorps est réactif avec des échantillons de Humain.
N° du produit ABIN7864702
639,45 €
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 6 à 10 jours ouvrables

Aperçu rapide pour Factor VII anticorps (AA 366-466) (ABIN7864702)

Antigène

Voir toutes Factor VII (F7) Anticorps
Factor VII (F7) (Coagulation Factor VII (F7))

Reactivité

  • 96
  • 14
  • 9
  • 5
  • 2
  • 2
  • 2
  • 1
  • 1
Humain

Hôte

  • 62
  • 40
  • 9
  • 2
  • 1
Souris

Clonalité

  • 75
  • 39
Monoclonal

Conjugué

  • 86
  • 15
  • 5
  • 4
  • 2
  • 1
  • 1
Cet anticorp Factor VII est non-conjugé

Application

  • 66
  • 54
  • 44
  • 18
  • 17
  • 17
  • 6
  • 5
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Immunohistochemistry (IHC), ELISA

Clone

F7-3515
  • Épitope

    • 27
    • 8
    • 6
    • 5
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 366-466

    Fonction

    Coagulation Factor VII / F7 Antibody

    Specificité

    Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin and Factors X, IX, V and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble Fibrin clots and the promotion of platelet aggregation. Coagulation Factor VII (serum prothrombin conversion accelerator, proconvertin, F7, Factor VII) is a 406 amino acid, vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor. Factor IX A, Factor X A, Factor XII A or Thrombin-mediated proteolytic cleavage of Factor VII at Arg 152-Ile 153 generates Factor VII A, an active serine protease composed of a catalytic heavy chain disulfide linked to a light chain, containing two EGF-like domains. Mutations at the F7 locus that lead to Factor VII deficiencies are generally asymptomatic or phenotypically uncharacterized, with hemorrhagic diathesis occurring at extremely low levels.

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogène

    Recombinant fragment (around aa 366-466) of human F7 protein

    Isotype

    IgG2, kappa
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
  • Antigène

    Factor VII (F7) (Coagulation Factor VII (F7))

    Autre désignation

    Coagulation Factor VII

    Sujet

    Eptacog alfa, Factor VII heavy chain, Factor VII light chain, FVII coagulation protein, Proconvertin, Serum prothrombin conversion accelerator (SPCA)

    Human liver or gastric carcinoma.

    Poids moléculaire

    200/80/73/50/43 kDa

    ID gène

    2155, 36989

    Pathways

    Response to Growth Hormone Stimulus, Platelet-derived growth Factor Receptor Signaling
Vous êtes ici:
Chat with us!